| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213722 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 7 Pages |
Abstract
Most patients with DLBCL who relapse and subsequently undergo HDC/ASCT initially recur in the previously involved disease site(s). Time to recurrence is brief, suggesting that frequency of screening is most justifiably greatest in the early posttherapy years. © 2016 Elsevier Inc.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sughosh MD, James E. MD, Carla MD, Jonathan W. MD, Michael W. MD, Jane L. MD, Louis S. MD,